Evidence so far suggests that the prevalence of long COVID in low- and middle-income countries could be similar to that of wealthier countries. For example, by some estimates, more than four million people in Brazil have long COVID.
However, an absence of research on the condition in less-wealthy countries has left advocates hamstrung: few physicians acknowledge that long COVID exists. A lack of data is also hampering efforts to search for the mechanisms of the condition and tailor treatments.
This is an audio version of our Feature Long COVID is a double curse in low-income nations — here’s why
Hosted on Acast. See acast.com/privacy for more information.
Coronapod: Dexamethasone, the cheap steroid that could cut coronavirus deaths
Incest in the elite of Neolithic Ireland
Long Read Podcast: Enigmatic neutron stars may soon give up their secrets
Coronapod: The Surgisphere scandal that rocked coronavirus drug research
The quantum space lab
#ShutDownSTEM and the Nature Podcast
Coronapod: The heavy toll on people of colour
Lab-made skin grows its own hair
Coronapod: The divisive hydroxychloroquine study that's triggering mass confusion
Super-efficient catalyst boosts hopes for hydrogen fuel
Coronapod: Hope and caution greet vaccine trial result, and Trump vs the WHO
A synthetic eye that 'sees' like a human
Coronapod: The misinformation pandemic, and science funding fears
The super-sleuth who spots trouble in science papers, and the puzzle of urban smog
Coronapod: The dangers of ignoring outbreaks in homeless shelters, plus coronavirus and drug abuse
07 May 2020: Galileo and the science deniers, and physicists probe the mysterious pion
Coronapod: What use are contact tracing apps? And new hopes for coronavirus drug remdesivir
30 April 2020: A sniff test for consciousness, and how to cut antibiotics use — with vaccines
Coronapod: The race to expand antibody testing
23 April 2020: Denisovan DNA in modern Europeans, and the birth of an unusual celestial object
Create your
podcast in
minutes
It is Free